Clinical Interests

Translation of novel clinical trials for patients with hematologic malignancies, especially multiple myeloma and lymphoma.

Education & Training

Degree-Granting Education

2011 Jinan University, Guangzhou, China, PHD, Internal Medicine

2002 Sun Yat-sen University, Guangzhou, China, MS, Internal Medicine

1996 Hunan Medical University, Changsha, China, BS, Medicine

Postgraduate Training

2005-2010 Hematological Clinical Fellow, Division of Hematology, Guangdong Provincial Hospital, Guangzhou，Guangdong

2002-2004 Residency, Internal Medicine, Guangdong Provincial Hospital, Guangzhou，Guangdong

1996-1999 Residency, Internal Medicine, Yuebei people’s Hospital, Shaoguan，Guangdong

Positions.

Positions and Employment

2011-present Associate professor, Division of Hematology, Guangdong Provincial Hospital, Guangzhou，Guangdong, China

Other Professional Experience

2013-2014 Visiting associate professor，Department of Lymphoma/Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

2001-2002 Research Assistant, Department of molecular biology, Division of life science, Hong Kong University of Science & Technology, Hong Kong, China

Professional Memberships

Section of Hematology, Chinese Society for Medicine, Committee Member

Section of Hematology, Chinese Anti-Cancer Association Committee Member

Chinese Chronic lymphocytic leukemia workgroup, Committee Member

Section of Hematology, Chinese Geriatrics Society, Committee Member

Guangdong Precision Medicine Application association, Committee Member

Publications

• Xiangsheng Zhang#, Liye Zhong#, Zhilin Zou, Guosheng Liang, Zhenye Tang, Kai Li, Shuzhen Tan, Yongmei Huang, Xiao Zhu. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases. Front Oncol. 2021;11:623170. doi: 10.3389/fonc.2021.623170.
• Miao Li , Lin Qi, JingBo Xu, LiYe Zhong , Szehoi Chan, ShuNa Chen, XinRong Shao, Li-Yuan Zheng, ZhaoXia Dong, TianLiang Fang, ZhiYing Mai, Juan Li, Yongjiang Zheng, XingDing Zhang. Methylation of the Promoter Region of the Tight Junction Protein-1 by DNMT1 Induces EMT-like Features in Multiple Myeloma. Mol Ther Oncolytics. 2020;19:197-207.
• LiYe Zhong, Du X, Geng SX, Weng JY, Zheng HT, Wu SJ, Li YQ. Expression of CD133 in the bone marrow of patients with myelodysplastic syndrome and its clinical significance. Journal of Southern Medical University. 2011;31(5):854-855,863 (in Chinese)
• LiYe Zhong, Du X, Geng SX, Weng JY, Zheng HT, Wu SJ, Li YQ. Expression of dipeptidyl peptidase 10 in patients with refractory anemia with excess blasts subtype of myelodysplastic syndromes. The Journal of Practical Medicine. 2011;27(9):1562-1564 (in Chinese)
• Zhong LY, Li QH, Huang LZ, Lin W, Lu ZS, Weng JY, Wu SJ,Du X. Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia. Chinese Journal of Cancer; 2009， 28（6）： 619－625
• LiYe Zhong, Liu TH, Geng SX, LU ZS, Weng JY, Wu SJ, Luo CW, Du X. Serum proteomics in patients with RAEB myelodysplastic syndromes. Journal of Southern Medical University. 2009;29(9):1799-1801,1806 (in Chinese)
• LiYe Zhong, Liu TH, Geng SX, Lu ZS, Weng JY, Wu SJ, Luo CW, Du X. Serum proteome in patients with RAEB myelodysplastic syndromes analyzed with MALDI-TOF-MS. Chinese Journal of Cancer Prevention and Treatment. 2009，16（21）：1625-1628 (in Chinese)
• LiYe Zhong, Liu TH, Geng SX, Lu ZS, Weng JY, Wu SJ, Luo CW, Du X. Study on serum proteomic spectra in patients with myelodysplastic syndromes. The Journal of Practical Medicine. 2009，25（21）：3586-3588 (in Chinese)
• LiYe Zhong, Liu TH, Lin XB, Du X, Lin W, Huang YQ,Zhong XY. Expression of hCDC6 mutation in acute myeloid leukemia. Journal of Leukemia & Lymphoma. 2006，15（3）：183-185 (in Chinese)
• LiYe Zhong, Liu TH, Lin XB, Chen YX. The Expression and Clinical Significance of CDC6 in Adult Patients with Acute Leukemia. Chinese Journal of Clinical Oncology. 2006;33(14):811-813 (in Chinese)
• LiYe Zhong, Liu T, Chen Y, Zhong X, Du X, Lu Z, Weng J, Wu S, Lin W. The study on effect of Sarcandra glabra on prevention and treatment of thrombocytopenia by chemotherapy. Zhong Yao Cai. 2005 Jan;28(1):35-8. (in Chinese)LiYe Zhong, Chen YX, Zhong XY, Liu TH, Ou RM, Zhao HY, Su WW, Lin W, Du X, Xu PL. Study on biological activity of thrombopoietin Ⅱ in vivo. Chinese Journal of Pathophysiology. 2001, 17( 4) : 346- 348 (in Chinese)